U.S. venture funding of therapeutic companies by disease type 2022
In 2022, venture funding in the U.S. for oncology totaled around 5.5 billion U.S. dollars, making it the second highest VC funded disease type. This statistic shows venture funding of U.S. therapeutic companies for the year 2022, sorted by disease, in million U.S. dollars.